In summary, the present study confirmed that EMX2OS can be used as a potential biomarker for the diagnosis of NS and is involved in the pathological process of NS-associated ALI by promoting ferroptosis through miR-654-3p/AKT3 signaling pathway. The gene discussed is EMX2OS; the disease is Netherton syndrome.